Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

2.

Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.

Kölzer M, Ferlinz K, Bartelsen O, Hoops SL, Lang F, Sandhoff K.

Biol Chem. 2004 Dec;385(12):1193-5.

PMID:
15653433
3.

Saposin fold revealed by the NMR structure of NK-lysin.

Liepinsh E, Andersson M, Ruysschaert JM, Otting G.

Nat Struct Biol. 1997 Oct;4(10):793-5.

PMID:
9334742
4.

Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).

Hiraiwa M, O'Brien JS, Kishimoto Y, Galdzicka M, Fluharty AL, Ginns EI, Martin BM.

Arch Biochem Biophys. 1993 Jul;304(1):110-6.

PMID:
8323276
5.

Crystal structure of saposin B reveals a dimeric shell for lipid binding.

Ahn VE, Faull KF, Whitelegge JP, Fluharty AL, Privé GG.

Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):38-43. Epub 2002 Dec 23.

7.

Effect of saposins on acid sphingomyelinase.

Tayama M, Soeda S, Kishimoto Y, Martin BM, Callahan JW, Hiraiwa M, O'Brien JS.

Biochem J. 1993 Mar 1;290 ( Pt 2):401-4.

8.

Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.

Kretz KA, Carson GS, Morimoto S, Kishimoto Y, Fluharty AL, O'Brien JS.

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2541-4.

9.

Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins.

Ferlinz K, Linke T, Bartelsen O, Weiler M, Sandhoff K.

Chem Phys Lipids. 1999 Nov;102(1-2):35-43. Review.

PMID:
11001559
10.

Human acid sphingomyelinase.

Lansmann S, Schuette CG, Bartelsen O, Hoernschemeyer J, Linke T, Weisgerber J, Sandhoff K.

Eur J Biochem. 2003 Mar;270(6):1076-88.

11.

The primary structure of mouse saposin.

Tsuda M, Sakiyama T, Endo H, Kitagawa T.

Biochem Biophys Res Commun. 1992 May 15;184(3):1266-72.

PMID:
1590788
12.

Structural and membrane-binding properties of saposin D.

Tatti M, Salvioli R, Ciaffoni F, Pucci P, Andolfo A, Amoresano A, Vaccaro AM.

Eur J Biochem. 1999 Jul;263(2):486-94.

13.

Conformational and amino acid residue requirements for the saposin C neuritogenic effect.

Qi X, Kondoh K, Krusling D, Kelso GJ, Leonova T, Grabowski GA.

Biochemistry. 1999 May 11;38(19):6284-91.

PMID:
10320358
14.

Structural analysis of saposin C and B. Complete localization of disulfide bridges.

Vaccaro AM, Salvioli R, Barca A, Tatti M, Ciaffoni F, Maras B, Siciliano R, Zappacosta F, Amoresano A, Pucci P.

J Biol Chem. 1995 Apr 28;270(17):9953-60.

15.

Saposin D: a sphingomyelinase activator.

Morimoto S, Martin BM, Kishimoto Y, O'Brien JS.

Biochem Biophys Res Commun. 1988 Oct 14;156(1):403-10.

PMID:
2845979
16.

Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins.

Linke T, Wilkening G, Lansmann S, Moczall H, Bartelsen O, Weisgerber J, Sandhoff K.

Biol Chem. 2001 Feb;382(2):283-90.

PMID:
11308026
17.

[Niemann-Pick disease types A and B].

Ohno K.

Nihon Rinsho. 1995 Dec;53(12):3014-8. Review. Japanese.

PMID:
8577051
18.

Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.

Qi X, Kondoh K, Yin H, Wang M, Ponce E, Sun Y, Grabowski GA.

Mol Genet Metab. 2002 Jul;76(3):189-200.

PMID:
12126932
20.

The amoebapore superfamily.

Zhai Y, Saier MH Jr.

Biochim Biophys Acta. 2000 Sep 18;1469(2):87-99. Review.

PMID:
10998571
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk